EMA Authorised: Sitagliptin Accord (sitagliptin hydrochloride) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Sitagliptin Accord (sitagliptin hydrochloride) for the treatment of type 2 diabetes mellitus; the product is a generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin Accord (sitagliptin hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Accord Healthcare S.L.U.. Decision date: 24/01/2025